Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition for treating increased blood viscosity and blood supply insufficiency of brain tissues

A technology of insufficient blood supply and blood viscosity, which is applied in the direction of drug combination, medical formula, cardiovascular system diseases, etc., can solve the problems of increased blood viscosity and no blood viscosity, and achieve the effect of preventing cerebral thrombosis

Inactive Publication Date: 2011-11-02
王逸兴
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is still no application for a pharmaceutical composition that can treat both increased blood viscosity and insufficient blood supply to brain tissue

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for treating increased blood viscosity and blood supply insufficiency of brain tissues

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Example 1 The biosynthetic human insulin intravenous injection was injected into the bottle of glucose intravenous injection with a micrometering syringe, and the number of days of continuous infusion and the number of days between courses of treatment after being made into medicine were shown in clinical trials as follows:

[0021] With 1000ml of glucose intravenous injection with 10% sugar content and 7lU biosynthetic human insulin intravenous injection, there was no adverse reaction on the first day of intravenous infusion, but there was hyperglycemia reaction after intravenous infusion on the second day, which manifested as renal failure. Swelling, blood pressure slightly increased, lasted for 3 hours and the symptoms disappeared. Use 1000ml of glucose intravenous injection with a sugar content of 10% and 13lU biosynthetic human insulin intravenous injection. After intravenous infusion, there is hypoglycemia reaction, manifested as palpitations, cold sweats, and gene...

Embodiment 2

[0024] Example 2 According to the results of drug clinical trials, 1000ml of glucose intravenous injection with a sugar content of 10% was selected to be mixed with 101U biosynthetic human insulin intravenous injection, and the biosynthetic human insulin intravenous injection was injected into the glucose intravenous injection with a micrometering syringe in the bottle. This is a dose once a day, 10 days a course of treatment, to achieve the following curative effect:

[0025] On the 5th day of the first course of intravenous infusion, the complexion changed from slightly blue to reddish. On the 7th day of intravenous infusion, the gastrointestinal function of digestion and absorption resumed (you can hear the sound of digestion), and the sleep time increased day by day. You must take 2 tablets of 1mg estazolam, 2 tablets of 1mg alprazolam, and 2 tablets of 25mg promethazine hydrochloride before you can fall asleep. After the first course of treatment, take sleeping pills and ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicinal composition for treating increased blood viscosity and blood supply insufficiency of brain tissues, and relates to a medicinal preparation. The medicinal composition is characterized in that: a glucose intravenous injection and a biosynthetic human insulin intravenous injection are prepared into an intravenous injection in the ratio that 1,000ml of the glucose intravenous injection with sugar content of 10 percent is mixed with 8-12 IU (International Unit) of the biosynthetic human insulin intravenous injection. In the medicinal composition, the two common medicaments are combined for use, so that the two diseases of increased blood viscosity and blood supply insufficiency of brain tissues can be treated. The medicinal composition has the advantages of no adverse effect, no side effect, safety and reliability for a human body; and since the structure of the biosynthetic human insulin intravenous injection is completely same as the structure of insulin secreted in the human body, the medicinal composition does not have anaphylactic response and can be used safely.

Description

technical field [0001] The invention relates to a pharmaceutical preparation, in particular to a pharmaceutical composition for treating increased blood viscosity and insufficient blood supply to brain tissue. Background technique [0002] Viscous blood is called hyperviscosity in medicine, and middle-aged and elderly people are prone to suffer from it. Blood viscosity can be divided into light, medium and heavy. Generally, mild blood viscosity is mostly physiological, often caused by excessive sweating, dehydration or too little drinking water. Patients with moderate to severe blood viscosity are often accompanied by hyperlipidemia. The increase in hematocrit makes the blood flow slow and prone to tissue stasis and hypoxia. Symptoms of coronary insufficiency such as chest tightness, and disturbance of consciousness may also occur. [0003] Cerebral insufficiency refers to the disorder of brain function caused by insufficient blood supply to a certain part of the human br...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/28A61P9/10A61K31/7004
Inventor 王逸兴
Owner 王逸兴
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com